These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32844952)

  • 1. Serum sclerostın levels ın chronıc otıtıs medıa wıth and wıthout cholesteatoma.
    Karali E; Yis OM
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):966-972. PubMed ID: 32844952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of EGF, IL1-α and IL-6 levels and selected hematological parameters (NLR, MPV) in patients with the chronic cholesteatomatous otitis media.
    Çandar T; Baklaci D; Bilgin E; Erdem D; Dalgıç M
    Acta Biochim Pol; 2022 Jul; 69(3):633-637. PubMed ID: 35878246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclastic activity in chronic otitis media with cholesteatoma-related bone destruction.
    Özgür A; Yemiş T; Başbulut E; Turgut NF; Özdemir D; Akgül G; Mehel DM; Çelebi M
    J Laryngol Otol; 2021 Oct; 135(10):879-882. PubMed ID: 34348812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in chronic otitis media.
    Baysal E; Aksoy N; Kara F; Taysi S; Taşkın A; Bilinç H; Cevik C; Celenk F; Kanlıkama M
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1203-8. PubMed ID: 22711004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of chronic suppurative otitis media on children's and teenagers' hearing.
    Silveira Netto LF; da Costa SS; Sleifer P; Braga ME
    Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1751-6. PubMed ID: 19853931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide concentration and bone resorption in cholesteatoma.
    Peek FA; Huisman MA; Berckmans RJ; Sturk A; Van Loon J; Grote JJ
    Otol Neurotol; 2003 Sep; 24(5):709-13. PubMed ID: 14501443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utilization of Chronic Otitis Media Questionnaire-12 in chronic otitis media with or without cholesteatoma.
    Demir B; Sahin A; Binnetoglu A; Batman C
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3037-3043. PubMed ID: 32424496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
    Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
    Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone resorption in chronic otitis media: the role of the osteoclast.
    Jung JY; Chole RA
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(2):95-107. PubMed ID: 12021500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
    Kinoshita K
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cholesteatomatous bone resorption with pamidronate disodium.
    Yoon TH; Lee SH; Park MH; Chung JW; Kim HJ
    Acta Otolaryngol; 2001 Jan; 121(2):178-81. PubMed ID: 11349773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclasts in chronic otitis media, cholesteatoma, and otosclerosis.
    Chole RA
    Ann Otol Rhinol Laryngol; 1988; 97(6 Pt 1):661-6. PubMed ID: 3202569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of differences in facial nerve dehiscence and ossicular injury in chronic otitis media and cholesteatoma.
    Choi SA; Kang HM; Byun JY; Park MS; Yeo SG
    Acta Otolaryngol; 2014 May; 134(5):455-61. PubMed ID: 24702225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically Assisted Dissection With Sodium 2-Mercaptoethanesulfonate (MESNA) in the Surgical Management of Pediatric Cholesteatoma.
    de la Torre C; Villamor P
    Otol Neurotol; 2019 Jun; 40(5):645-650. PubMed ID: 31083092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of Feldmann's osteoplastic approach for chronic middle ear disease].
    Yazawa Y; Kitano H; Suzuki M; Kodama A; Kitajima K
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Dec; 99(12):1746-50. PubMed ID: 8997092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destruction of ossicles in chronic otitis media.
    Kärjä J; Jokinen K; Seppälä A
    J Laryngol Otol; 1976 Jun; 90(6):509-18. PubMed ID: 819605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm's Role in Chronic Cholesteatomatous Otitis Media: A Pilot Study.
    Galli J; Calò L; Giuliani M; Sergi B; Lucidi D; Meucci D; Bassotti E; Sanguinetti M; Paludetti G
    Otolaryngol Head Neck Surg; 2016 May; 154(5):914-6. PubMed ID: 26932953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.